These 4 Bullets say it all...now we wait for t
Post# of 72440
Brilacidin potently inhibits SARS-CoV-2 in an ACE2 positive human lung cell line.
Brilacidin achieved a high Selectivity Index of 426 (CC50=241μM/IC50=0.565μM).
Brilacidin’s main mechanism appears to disrupt viral integrity and impact viral entry.
Brilacidin and remdesivir exhibit excellent synergistic activity against SARS-CoV-2.
RP